Sector Update: Healthcares


Shutterstock photo

Healthcare shares are flat to lower in pre-market trade.

In healthcare stocks news, Dendreon Corp ( DNDN ) rose nearly 18% in pre-market trading after a Bloomberg report said the company is seeking a buyer and has hired JPMorgan Chase & Co to help with the search.

Citing unnamed people with knowledge of the situation, Bloomberg said the strategic shift resulted after the company's prostate cancer treatment drug sales failed to meet expectations.

In contrast, Synta Pharmaceuticals ( SNTA ) is down 19.2% this morning after it announced presentation of results from the GALAXY-1 trial, a global, randomized, multi-center study designed to identify the patients with advanced non-small cell lung adenocarcinoma most likely to benefit from second-line treatment with the company's lead drug candidate, the Hsp90 inhibitor ganetespib, in combination with docetaxel versus docetaxel alone.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities
More Headlines for: DNDN , SNTA

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by